📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Amplyx

1.1 - Company Overview

Amplyx Logo

Amplyx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pre-clinical small-molecule therapeutics for debilitating and life-threatening diseases in patients with compromised immune systems, employing a platform approach that enhances efficacy and lowers toxicity by adding a second small molecule to existing drugs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Amplyx

PBD Biotech Logo

PBD Biotech

HQ: United Kingdom Website
  • Description: Provider of clinical-stage phage-based diagnostics for tuberculosis, developing Actiphage TB, a blood-based test that detects Mycobacterium tuberculosis, supporting latent TB screening, active infection detection, and drug management.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PBD Biotech company profile →
RQx Pharmaceuticals Logo

RQx Pharmaceuticals

HQ: United States Website
  • Description: Provider of broad spectrum antibiotic development; a biopharmaceutical company founded in 2010 and based in La Jolla, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RQx Pharmaceuticals company profile →
Turn Therapeutics Logo

Turn Therapeutics

HQ: United States Website
  • Description: Provider of pharmaceutical solutions to reduce the human and economic costs of infection and skin disease, including PermaFusion petrolatum-based liquid-in-oil suspension technology for high-bioavailability delivery; Hexagen FDA-cleared antimicrobial wound dressing; a pre-operative nasal decolonization program targeting MRSA; and onychomycosis treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Turn Therapeutics company profile →
IncellDx Logo

IncellDx

HQ: United States Website
  • Description: Provider of molecular diagnostics focused on detecting and monitoring life-threatening viral diseases, offering HPV OncoTect 3Dx assay quantifying E6/E7 mRNA for cervical cancer; incellKINE Long COVID in vitro diagnostic (CE marked); HPV E6/E7 mRNA probe; CMV mRNA probe (RUO); hybridization core reagents; and HPV control cells (RUO).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IncellDx company profile →
Fio Logo

Fio

HQ: Canada Website
  • Description: Provider of a point-of-care medical device used to gather data through interactions with a healthcare system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Amplyx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Amplyx

2.2 - Growth funds investing in similar companies to Amplyx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Amplyx

4.2 - Public trading comparable groups for Amplyx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Amplyx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Amplyx

What does Amplyx do?

Amplyx is a provider of pre-clinical small-molecule therapeutics for debilitating and life-threatening diseases in patients with compromised immune systems, employing a platform approach that enhances efficacy and lowers toxicity by adding a second small molecule to existing drugs.

Who are Amplyx's competitors?

Amplyx's competitors and similar companies include PBD Biotech, RQx Pharmaceuticals, Turn Therapeutics, IncellDx, and Fio.

Where is Amplyx headquartered?

Amplyx is headquartered in United States.

How many employees does Amplyx have?

Amplyx has 1,000 employees 🔒.

When was Amplyx founded?

Amplyx was founded in 2010 🔒.

What sector and industry vertical is Amplyx in?

Amplyx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Amplyx

Who are the top strategic acquirers in Amplyx's sector and industry

Top strategic M&A buyers and acquirers in Amplyx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Amplyx?

Top strategic M&A buyers groups and sectors for Amplyx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Amplyx's sector and industry vertical

Which are the top PE firms investing in Amplyx's sector and industry vertical?

Top PE firms investing in Amplyx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Amplyx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Amplyx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Amplyx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Amplyx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Amplyx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Amplyx?

The key public trading comparables and valuation benchmarks for Amplyx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Amplyx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Amplyx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Amplyx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Amplyx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Amplyx's' sector and industry vertical?

Access recent funding rounds and capital raises in Amplyx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Amplyx